BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26809267)

  • 1. Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer.
    Wang N; He T; Shen Y; Song L; Li L; Yang X; Li X; Pang M; Su W; Liu X; Wu Q; Gong C
    ACS Appl Mater Interfaces; 2016 Feb; 8(7):4368-77. PubMed ID: 26809267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antiproliferative and apoptosis effect of paclitaxel-loaded polymeric micelles against non-small cell lung cancers.
    Zhang XY; Zhang YD
    Tumour Biol; 2015 Jul; 36(7):4949-59. PubMed ID: 25702089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers.
    Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW
    Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-Loaded Mixed Micelles Enhance Ovarian Cancer Therapy through Extracellular pH-Triggered PEG Detachment and Endosomal Escape.
    Zhao H; Li Q; Hong Z
    Mol Pharm; 2016 Jul; 13(7):2411-22. PubMed ID: 27266442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
    Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y
    Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors.
    Wang Y; Hao J; Li Y; Zhang Z; Sha X; Han L; Fang X
    Biomaterials; 2012 Jun; 33(18):4741-51. PubMed ID: 22445254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
    Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
    Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
    Cho H; Lai TC; Kwon GS
    J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
    Zhao D; Zhang H; Yang S; He W; Luan Y
    Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously.
    Li X; Li P; Zhang Y; Zhou Y; Chen X; Huang Y; Liu Y
    Pharm Res; 2010 Aug; 27(8):1498-511. PubMed ID: 20411408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance.
    Wan CP; Letchford K; Jackson JK; Burt HM
    Int J Nanomedicine; 2013; 8():379-91. PubMed ID: 23378760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
    Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
    Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
    Zhang L; He Y; Ma G; Song C; Sun H
    Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
    Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
    Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor.
    Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X
    Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance.
    Li J; Xu R; Lu X; He J; Jin S
    Int J Nanomedicine; 2017; 12():8043-8056. PubMed ID: 29138561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
    Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel.
    Ouahab A; Shao C; Shen Y; Tu J
    Drug Dev Ind Pharm; 2014 Jul; 40(7):860-8. PubMed ID: 23600653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.